Working... Menu
Trial record 66 of 514 for:    ALS (Amyotrophic Lateral Sclerosis)

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02794857
Recruitment Status : Completed
First Posted : June 9, 2016
Last Update Posted : May 7, 2018
Information provided by (Responsible Party):
Neuraltus Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 12, 2017
  Actual Study Completion Date : December 12, 2017